References
- Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011;30:300–305.
- Kenan K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010. Open Med. 2012;6:e41–e47.
- Hasegawa K, Brown DF, Tsugawa Y, et al. Epidemiology of emergency department visits for opioid overdose: a population-based study. Mayo Clin Proc. 2014;89:462–471.
- Manchikanti L, Atluri S, Candido KD, et al. Zohydro approval by food and drug administration: controversial or frightening? Pain Phys. 2014;17:E437–E450.
- Aitken M. Medicines use and spending shifts: a review of the use of medicines in the US in 2014 1999. IMS Institute for Healthcare Informatics. 2015.
- Control CD. Prevention. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004–2008. MMWR Morb Mortal Wkly Rep. 2010;59:705–709.
- Wang KH, Fiellin DA, Becker WC. Source of prescription drugs used nonmedically in rural and urban populations. Am J Drug Alcohol Abuse. 2014;40:292–303.
- Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008–2011. JAMA Intern Med. 2014;174:802–803.
- FDA. Statement on proposed hydrocodone relcassification from Janet Woodcock, MD, Director, Center for Drug Evaluation and Research. 2013. Available from: http://wwwfdagov/Drugs/DrugSafety/ucm372089htm.
- US DOJ D. Title 21 Code of Federal Regulations 1308.11 through 1308.15. 2015. Available from: http://wwwdeadiversionusdojgov/21cfr/cfr/2108cfrthtm.
- Drug Enforcement Administration DoJ. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule. Fed Regist. 2014;79:49661–49682.
- Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. 2013;132:95–100.
- Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574.
- AAPCC. American Association of Poison Control Centers National Poison Data System (NPDS) Reference Manual Part 2 - System Information Manual. 2007.
- US Department of Health and Human Serrvices, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Drug Abuse Warning Network (DAWN) National and Metro Tables, 2004–2011 (“All misuse and abuse”). 2013. Available from: http://wwwsamhsagov/data/DAWNaspx#DAWN.
- Use of codeine- and dextromethorphan-containing cough remedies in children. American Academy of Pediatrics. Committee on Drugs. Pediatrics. 1997;99:918–920.
- AAP Publications Retired or Reaffirmed October 2006. Pediatrics. 2007;119:450.
- Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. Clin Pharmacokinet. 2009;48:761–804.